Priming effect of orally administered muramyl dipeptide on induction of endogenous tumor necrosis factor.

T Okutomi, H Inagawa, T Nishizawa, H Oshima, G Soma, D Mizuno
{"title":"Priming effect of orally administered muramyl dipeptide on induction of endogenous tumor necrosis factor.","authors":"T Okutomi,&nbsp;H Inagawa,&nbsp;T Nishizawa,&nbsp;H Oshima,&nbsp;G Soma,&nbsp;D Mizuno","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>Orally administered muramyl dipeptide (MDP) was found to prime induction of endogenous tumor necrosis factor (TNF) in mice. This priming effect was observed after oral administration of MDP of more than 100 micrograms/mouse; the maximal time interval between oral administration of MDP and i.v. injection of OK-432, a triggering agent for induction of endogenous TNF, was extended over 3-10 h and then decreased after 24 h. Antitumor effect against Meth-A, MH134, and MM46 tumor cells in mice was observed after oral administration of MDP followed by i.v. injection of OK-432. These findings suggest that orally administered MDP can be used as a priming agent for inducing endogenous TNF in cancer patients, and that MDP, a component of enteric bacteria, must have an important role in maintaining homeostasis through activation of macrophages.</p>","PeriodicalId":15063,"journal":{"name":"Journal of biological response modifiers","volume":"9 6","pages":"564-9"},"PeriodicalIF":0.0000,"publicationDate":"1990-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of biological response modifiers","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Orally administered muramyl dipeptide (MDP) was found to prime induction of endogenous tumor necrosis factor (TNF) in mice. This priming effect was observed after oral administration of MDP of more than 100 micrograms/mouse; the maximal time interval between oral administration of MDP and i.v. injection of OK-432, a triggering agent for induction of endogenous TNF, was extended over 3-10 h and then decreased after 24 h. Antitumor effect against Meth-A, MH134, and MM46 tumor cells in mice was observed after oral administration of MDP followed by i.v. injection of OK-432. These findings suggest that orally administered MDP can be used as a priming agent for inducing endogenous TNF in cancer patients, and that MDP, a component of enteric bacteria, must have an important role in maintaining homeostasis through activation of macrophages.

分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
口服muramyl二肽诱导内源性肿瘤坏死因子的启动效应。
口服鼠戊二肽(MDP)对小鼠内源性肿瘤坏死因子(TNF)有主要诱导作用。在口服MDP≥100微克/只后观察到这种启动效应;口服MDP与静脉注射内源性TNF触发剂OK-432的最大时间间隔在3-10 h内延长,24 h后缩短。口服MDP后静脉注射OK-432,观察其对小鼠Meth-A、MH134和MM46肿瘤细胞的抗肿瘤作用。这些研究结果表明,口服MDP可作为肿瘤患者诱导内源性TNF的启动剂,并且MDP作为肠道细菌的一种成分,通过激活巨噬细胞在维持体内平衡中发挥重要作用。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Interferon protects normal human granulocyte/macrophage colony-forming cells from Ara-C cytotoxicity. Effects of granulocyte colony-stimulating factor on hematopoietic injury induced by anticancer drugs in mice. Receptors for human plasminogen on the biological response modifier OK-432. A phase I study of high-dose interleukin-2 in combination with interferon-alpha 2b. Phase I trial of continuous infusion recombinant interleukin-2 and intermittent recombinant interferon-alpha 2a: clinical effects.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1